Free Trial

Totally (TLY) Competitors

Totally logo
GBX 1.50 +0.10 (+7.14%)
As of 05/2/2025 12:26 PM Eastern

TLY vs. KNB, SPI, MGP, SBI, COS, C4XD, DDDD, FUM, AGL, and NCYT

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Futura Medical (FUM), ANGLE (AGL), and Novacyt (NCYT). These companies are all part of the "medical" sector.

Totally vs.

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations.

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
TotallyOutperform Votes
131
72.38%
Underperform Votes
50
27.62%
Kanabo GroupN/AN/A

In the previous week, Totally had 1 more articles in the media than Kanabo Group. MarketBeat recorded 2 mentions for Totally and 1 mentions for Kanabo Group. Totally's average media sentiment score of 0.00 beat Kanabo Group's score of -0.45 indicating that Totally is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Totally
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kanabo Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Totally has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.

51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by insiders. Comparatively, 37.0% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Totally presently has a consensus target price of GBX 20, suggesting a potential upside of 1,233.33%. Given Totally's stronger consensus rating and higher probable upside, equities research analysts plainly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.85% -11.01% -2.42%
Kanabo Group -717.63%-121.77%-20.89%

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.02-£3.79M-£1.93-0.78
Kanabo Group£1.14M1.25-£8.18M-£1.29-0.17

Summary

Totally beats Kanabo Group on 12 of the 17 factors compared between the two stocks.

Get Totally News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£2.95M£1.51B£5.55B£2.62B
Dividend Yield13.16%3.83%5.09%4.94%
P/E Ratio-0.787.0622.71134.19
Price / Sales0.0212.84405.55242,626.49
Price / Cash9.0812.5138.1828.26
Price / Book0.091.946.794.51
Net Income-£3.79M£58.65M£3.22B£5.91B
7 Day Performance-62.85%0.36%3.36%3.48%
1 Month Performance-62.50%1.72%6.92%12.12%
1 Year Performance-71.43%11.63%16.17%26.38%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLY
Totally
2.5172 of 5 stars
GBX 1.50
+7.1%
GBX 20
+1,233.3%
-71.4%£2.95M£133.05M-0.781,668Analyst Forecast
News Coverage
Gap Down
High Trading Volume
KNB
Kanabo Group
N/AGBX 0.29
+15.2%
N/A-88.8%£1.82M£1.14M-0.2220News Coverage
Gap Down
SPI
Spire Healthcare Group
2.0747 of 5 stars
GBX 183.40
+1.3%
GBX 300
+63.6%
-20.1%£736.48M£1.44B26.10420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
COS
Collagen Solutions plc (COS.L)
N/AN/AN/AN/A£30.99M£4.01M-8.283,350
C4XD
C4X Discovery
N/AN/AN/AN/A£30.27M£24.68M300.0049High Trading Volume
DDDD
4D pharma
N/AN/AN/AN/A£30.05M£718,000.00-1.08106News Coverage
FUM
Futura Medical
N/AGBX 9.62
+3.4%
N/A-73.7%£29.98M£8.68M-7.9412Gap Up
AGL
ANGLE
1.6937 of 5 stars
GBX 9
-2.7%
GBX 40
+344.4%
-38.9%£29.00M£2.44M-1.33650
NCYT
Novacyt
N/AGBX 40.07
-1.6%
N/A-46.0%£27.68M£18.12M-0.74120Earnings Report
News Coverage
Gap Down

Related Companies and Tools


This page (LON:TLY) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners